Melanoma/Skin Cancer

Top Story

Indoor tanning declines, but more melanoma prevention efforts urgently needed

July 31, 2015

Melanoma rates in the United States doubled between 1982 and 2011, according to a CDC report.

“The sobering news is that, in 2011, there were more than 65,000 cases of melanoma, and more than 9,000 people die from melanoma every year,” Gery P. Guy Jr., PhD, MPH,  health economist in the CDC’s Division of Cancer Prevention and Control, told HemOnc Today.

SupplementPublication Exclusive

Perspectives from ASCO 2015: A HemOnc Today Special Report

HemOnc Today, July 25, 2015
This year’s ASCO Annual Meeting featured the theme “Illumination and Innovation: Transforming Data into Learning.”As such, meeting organizers selected…
In the Journals

BRAF inhibitors, Tafinlar/Mekinist for metastatic melanoma differed in cutaneous toxic effects

July 24, 2015
Cutaneous toxic effects differed between Tafinlar, Zelboraf or a combination of Tafinlar and Mekinist in patients with metastatic melanoma, according to recently…
FDA News

FDA grants priority review of Tafinlar/Mekinist for adults with BRAF V600 mutation-positive melanoma

July 24, 2015
Novartis announced that the FDA has granted priority review of the combination of Tafinlar and Mekinist for adults with unresectable or metastatic melanoma with a BRAF
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage Video
VIDEO: Patients with albinism have advanced skin cancer risk

VIDEO: Patients with albinism have advanced skin cancer risk

June 18, 2015
VANCOUVER — In this video, Roderick Hays, MD, FRCP, discusses risks facing patients with albinism, including…
More »
CME
PD-1 Antibodies

PD-1 Antibodies

This activity is supported by educational grants from Bristol-Myers Squibb, Delcath Systems, Inc., Merck & Co., Inc., OncoSec Medical, Inc., Prometheus and Provectus Pharmaceuticals, Inc.

This activity will review data on the efficacy, safety, and response patterns observed with PD-1 in patients with…
More »
Darren Mays, PhD, MPH

Indoor tanning declines, but more melanoma prevention efforts urgently needed

July 31, 2015
Melanoma rates in the United States doubled between 1982 and 2011, according to a CDC report.“The sobering news is that, in 2011, there were…
SupplementPublication Exclusive

Perspectives from ASCO 2015: A HemOnc Today Special Report

HemOnc Today, July 25, 2015
This year’s ASCO Annual Meeting featured the theme “Illumination and Innovation: Transforming Data into Learning.”As such, meeting…
In the Journals

BRAF inhibitors, Tafinlar/Mekinist for metastatic melanoma differed in cutaneous toxic effects

July 24, 2015
Cutaneous toxic effects differed between Tafinlar, Zelboraf or a combination of Tafinlar and Mekinist in patients with metastatic melanoma, according…
FDA News

FDA grants priority review of Tafinlar/Mekinist for adults with BRAF V600 mutation-positive melanoma

July 24, 2015
Novartis announced that the FDA has granted priority review of the combination of Tafinlar and Mekinist for adults with unresectable or metastatic…
FDA News

FDA approves Odomzo for locally advanced basal cell carcinoma

July 24, 2015
The FDA today announced the approval of sonidegib for the treatment of patients with locally advanced basal cell carcinoma.Sonidegib (Odomzo…
Marianne Berwick, PhD, MPH In the Journals

Citrus consumption may increase malignant melanoma risk

July 23, 2015
The consumption of citrus fruits corresponded with an increased risk for malignant melanoma in two independent cohorts, according to study…

European Commission approves Keytruda for treating advanced melanoma

July 23, 2015
Merck announced that the European Commission has approved Keytruda for treating unresectable or metastatic melanoma in adults, according to a press…
Antonio Tejera-Vaquerizo, MD In the Journals

Early SLNB may worsen melanoma-specific survival, DFS

July 21, 2015
A sentinel lymph node biopsy within 40 days of tumor excision appeared to worsen survival in patients with cutaneous melanoma compared with a delayed…

What are melanoma symptoms?

July 20, 2015
Melanoma is the most dangerous form of skin cancer. It develops in the melanocytes, which are cells that produce the pigment responsible for skin…
In the Journals

Patients with multiple cutaneous SCCs at higher risk for metastases, recurrence

July 17, 2015
Patients with multiple cutaneous squamous cell carcinomas had a higher risk of local recurrence and nodal metastases compared with patients with only…
More Headlines »